Clinical Trial Update: The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for CM326 in moderate-to-severe atopic dermatitis (Phase 1/Phase 2) with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• CM326

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Moderate-to-severe Atopic Dermatitis | Phase 1, Phase 2 | Status: UNKNOWN